Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in New York, NY, specializing in the development of gene and cell therapies aimed at addressing rare, life-threatening genetic disorders. The company is committed to innovating therapeutic solutions through its proprietary technologies and extensive clinical development pipeline, targeting significant unmet medical needs. With a focus on improving patient outcomes, Abeona strives to redefine the field of genetic therapies and create a comprehensive portfolio of treatment options for patients facing severe health challenges.